2092 related articles for article (PubMed ID: 18926148)
21. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
22. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
Gheorghiade M; Rossi JS; Cotts W; Shin DD; Hellkamp AS; Piña IL; Fonarow GC; DeMarco T; Pauly DF; Rogers J; DiSalvo TG; Butler J; Hare JM; Francis GS; Stough WG; O'Connor CM
Arch Intern Med; 2007 Oct; 167(18):1998-2005. PubMed ID: 17923601
[TBL] [Abstract][Full Text] [Related]
23. Does oxygen saturation or distance walked predict rehospitalization in heart failure?
Howie-Esquivel J; Dracup K
J Cardiovasc Nurs; 2008; 23(4):349-56. PubMed ID: 18596499
[TBL] [Abstract][Full Text] [Related]
24. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB
Am J Cardiol; 2008 Dec; 102(11):1524-9. PubMed ID: 19026308
[TBL] [Abstract][Full Text] [Related]
25. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.
Peterson PN; Rumsfeld JS; Liang L; Albert NM; Hernandez AF; Peterson ED; Fonarow GC; Masoudi FA;
Circ Cardiovasc Qual Outcomes; 2010 Jan; 3(1):25-32. PubMed ID: 20123668
[TBL] [Abstract][Full Text] [Related]
26. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
[TBL] [Abstract][Full Text] [Related]
27. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF.
Fonarow GC
Rev Cardiovasc Med; 2004; 5 Suppl 1():S45-54. PubMed ID: 15184838
[TBL] [Abstract][Full Text] [Related]
28. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
[TBL] [Abstract][Full Text] [Related]
29. A simple clinically based predictive rule for heart failure in-hospital mortality.
Rohde LE; Goldraich L; Polanczyk CA; Borges AP; Biolo A; Rabelo E; Beck-Da-Silva L; Clausell N
J Card Fail; 2006 Oct; 12(8):587-93. PubMed ID: 17045176
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.
Filippatos G; Rossi J; Lloyd-Jones DM; Stough WG; Ouyang J; Shin DD; O'connor C; Adams KF; Orlandi C; Gheorghiade M
J Card Fail; 2007 Jun; 13(5):360-4. PubMed ID: 17602982
[TBL] [Abstract][Full Text] [Related]
31. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
[TBL] [Abstract][Full Text] [Related]
32. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
33. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.
O'Connor CM; Mentz RJ; Cotter G; Metra M; Cleland JG; Davison BA; Givertz MM; Mansoor GA; Ponikowski P; Teerlink JR; Voors AA; Fiuzat M; Wojdyla D; Chiswell K; Massie BM
Eur J Heart Fail; 2012 Jun; 14(6):605-12. PubMed ID: 22535795
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial.
Huynh BC; Rovner A; Rich MW
Arch Intern Med; 2006 Sep; 166(17):1892-8. PubMed ID: 17000947
[TBL] [Abstract][Full Text] [Related]
35. A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Nunez E; Yancy CW; Young JB
Eur Heart J; 2008 Aug; 29(16):1983-91. PubMed ID: 18487210
[TBL] [Abstract][Full Text] [Related]
36. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
[TBL] [Abstract][Full Text] [Related]
37. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
38. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
Jhund PS; Macintyre K; Simpson CR; Lewsey JD; Stewart S; Redpath A; Chalmers JW; Capewell S; McMurray JJ
Circulation; 2009 Feb; 119(4):515-23. PubMed ID: 19153268
[TBL] [Abstract][Full Text] [Related]
39. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
[TBL] [Abstract][Full Text] [Related]
40. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
